A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by ...
The number of cases of mpox, formerly known as monkeypox, has spiked in the Big Apple since October, the New York City ...
The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
Mpox, formerly known as monkeypox, cases are on the rise here in the U.S., with nearly double the number of infections ...
Lower dose of monkeypox vaccine is found to be safe with equal six-week antibody response, promising for vaccination strategies.
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
Research suggests booster doses may be necessary for monkeypox immunity ... In contrast, for previously vaccinated individuals, the median titer 28 days after a single dose of the MVA-BN vaccine ...
KINSHASA, Congo (AP) — Congo is struggling to contain its biggest mpox outbreak, and scientists say a new form of the disease ...
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect ...
World Immunization Week: 507 vaccines in late-stage development, 88 using mRNA tech to prevent TB, malaria, flu, COVID-19, ...
A regulatory decision is expected on February 14, 2025. The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY ...
Older adults age 65 and over can now get another COVID vaccine this spring, after the Centers for Disease and Control and Prevention (CDC) formally recommended an extra shot for this age group. The ...